ANJI MICRO (688019.SH): Files H-share issuance and listing application with HKEX
NewTimeSpace News: On 3 September 2026, Anji Microelectronics Technology (Shanghai) Co., Ltd. (stock code: 688019.SH) announced that on 2 September 2026 it had filed its application for the issuance of H shares and listing on the Hong Kong Stock Exchange in confidential form. The Company had previously approved the relevant resolutions on the issuance of H shares and listing on the Hong Kong Stock Exchange at the fourth meeting of the fourth session of its board of directors held on 13 July 2026 and the second extraordinary general meeting of 2026 held on 5 August 2026.
The Company will complete the filing procedures with the China Securities Regulatory Commission (CSRC) in accordance with relevant laws and regulations. The H-share issuance and listing remains subject to the filing, approval or consent of the CSRC, the Hong Kong Securities and Futures Commission, the Hong Kong Stock Exchange and other relevant authorities, and there remains uncertainty as to whether the necessary filings, approvals or consents will be obtained and the timing thereof; the Company reminded investors to make cautious decisions and be aware of investment risks.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- FIRST CAP GP (01269.HK): Winding-Up Petition Hearing Adjourned to 1 February 2027, Scheme Meeting Hearing on 19 November
- GOLDWIND (02208.HK): 2027 Product Sales Framework Agreement with Xinjiang Wind Power, Annual Cap RMB 180.72mn
- GF SEC (01776.HK): RMB 370mn Advance Compensation Fund Set Up for Qingyue Technology Case
- ZAI LAB (09688.HK): Zoci Plus Atezolizumab in First-Line ES-SCLC Yields 81.8% Confirmed ORR
- CHIFENG GOLD (06693.HK): Q3 Net Profit Down 41.84% to RMB 553mn; 2026 Gold Output Target Raised to 12.5-13 Tonnes